Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎ New York, NY
(646) 856-9261
info@rgenix.com

News

H.C. Wainwright 22nd Annual Global Investment Conference

Canaccord Genuity 40th Annual Growth Conference

2020 Wedbush PacGrow Healthcare Conference

BTIG Virtual Biotechnology Conference 2020

LifeSci Partners Summer Symposium